KEEPING UP WITH THE KOLs: Breast tumor localization
This article was originally published in Clinica
Executive Summary
Key opinion leaders are fundamental in the early adoption of new technologies, be they innovations from big corporates or early stage ventures. In this new interview series, KOLs discuss their experience with a specific new technology and provide insight on where there might be more opportunity for innovation. The spotlight in this first article is on Dr Charles Cox, director of the Comprehensive Breast Cancer Program at the University of South Florida in Tampa and an innovator in breast tumor localization techniques. He chats to Clinica about his experience with Cianna Medical’s SAVI SCOUT surgical guidance system and how it compares with current methods for surgical localization of non-palpable breast tumors
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.